Moolec Science Balance Sheet Health

Financial Health criteria checks 1/6

Moolec Science has a total shareholder equity of $6.8M and total debt of $14.3M, which brings its debt-to-equity ratio to 209.2%. Its total assets and total liabilities are $34.8M and $28.0M respectively.

Key information

209.2%

Debt to equity ratio

US$14.26m

Debt

Interest coverage ration/a
CashUS$5.39m
EquityUS$6.82m
Total liabilitiesUS$27.97m
Total assetsUS$34.79m

Recent financial health updates

Is Moolec Science (NASDAQ:MLEC) Using Too Much Debt?

Aug 06
Is Moolec Science (NASDAQ:MLEC) Using Too Much Debt?

Is Moolec Science (NASDAQ:MLEC) A Risky Investment?

Apr 22
Is Moolec Science (NASDAQ:MLEC) A Risky Investment?

Recent updates

Is Moolec Science (NASDAQ:MLEC) Using Too Much Debt?

Aug 06
Is Moolec Science (NASDAQ:MLEC) Using Too Much Debt?

Is Moolec Science (NASDAQ:MLEC) A Risky Investment?

Apr 22
Is Moolec Science (NASDAQ:MLEC) A Risky Investment?

Financial Position Analysis

Short Term Liabilities: MLEC's short term assets ($13.7M) exceed its short term liabilities ($8.2M).

Long Term Liabilities: MLEC's short term assets ($13.7M) do not cover its long term liabilities ($19.8M).


Debt to Equity History and Analysis

Debt Level: MLEC's net debt to equity ratio (130.1%) is considered high.

Reducing Debt: Insufficient data to determine if MLEC's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: MLEC has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: MLEC has less than a year of cash runway if free cash flow continues to reduce at historical rates of 42.4% each year


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 19:53
End of Day Share Price 2024/12/24 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Moolec Science SA is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Anthony VendettiMaxim Group
Brian WrightRoth MKM